Invitrogen buys into Novell's SUSE Linux
Submitted by srlinuxx on Wed, 07/02/2008 - 21:37.
Invitrogen is a billion-dollar supplier to pharmaceutical and biotechnology companies, with 4,700 employees worldwide and a history of supplying many of the world's leading laboratories in groundbreaking research like the discovery of the AIDS virus.
To help promote its innovative work, Invitrogen announced this week that it is standardizing on Novell's SUSE® Linux Enterprise for its servers. Indeed, the press release calls out Invitrogen's adoption of Novell's new PlateSpin technology, which helps companies manage data center virtualization.
Platespin and Novel acquisitions ? Niche markets ?
Novell had made a few acqusitions. Platespin had some customers already. They are in Microsoft data centers.